Preventing Sexual and Intimate Partner Violence Within Racial/Ethnic Minority Communities, 17086-17093 [05-6580]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 70, Number 63 (Monday, April 4, 2005)]
[Notices]
[Pages 17086-17093]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-6580]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Preventing Sexual and Intimate Partner Violence Within Racial/
Ethnic Minority Communities

    Announcement Type: New.
    Funding Opportunity Number: RFA 05043.
    Catalog of Federal Domestic Assistance Number: 93.136.
    Key Dates: Letter of Intent Deadline: May 4, 2005.
    Application Deadline: May 19, 2005.

I. Funding Opportunity Description

    Authority: This program is authorized under section 391(a) of 
the Public Health Service Act (PHS Act), 42 U.S.C. 280b(a), section 
393 of the PHS Act, 42 U.S.C. 280b-1a.

Background

    The National Violence Against Women Survey (NVAWS) reports that 
approximately 1.5 million women are raped and/or physically assaulted 
by an intimate partner each year. Violence against women is a 
significant public health and criminal justice concern which 
disproportionately affects marginalized groups such as racial and 
ethnic minorities. This study further reports the racial and ethnic 
differences in the lifetime rates of rape, for example American Indian/
Alaska Native women were identified as having almost twice the rate of 
African American or White women. Specifically, American Indian/Alaska 
Native women (34 percent) were significantly more likely to report that 
they were raped than African American women (19 percent) or White women 
(18 percent). The survey also found that women who identified 
themselves as Hispanic (14.6 percent) were significantly less likely to 
report they had ever been raped than women who identified themselves as 
non-Hispanic (18.4 percent). Additionally, American Indian/Alaska 
Native women (30.7 percent) were most likely to report Intimate Partner 
Violence, and Asian/Pacific Islander women (12.8 percent) were least 
likely to report Intimate Partner Violence. Other racial differences 
illustrate that close to one-third of African American women experience 
intimate partner violence in their lifetimes compared with one-fourth 
of White women. Furthermore, when you consider the rates for the most 
severe form of intimate partner violence, which is homicide, African 
American women (3.55) are three times as likely than White women (1.11) 
to die

[[Page 17087]]

as a result of intimate partner violence (CDC, 2001). There was little 
difference found in Hispanic (21.2 percent) and non-Hispanic women's 
(22.1 percent) reports of intimate partner violence.
    More women than men experience intimate partner violence. According 
to the NVAWS, one out of four U.S. women has been physically assaulted 
or raped by an intimate partner and 1 out of every 14 U.S. men reported 
such an experience (Tjaden & Thoennes, 2000). Although women exhibit 
violent behavior in relationships with men and violence is also 
sometimes found in same sex partnerships, the overwhelming burden of 
intimate partner violence is experienced by women at the hands of men. 
Studies have consistently shown that in the case of female victims of 
sexual abuse, over 90 percent of the perpetrators are men (World Report 
on Violence and Health, 2002). Also, data from the NVAWS shows that 
91.9 percent of the women reported that they were physically assaulted 
by a male (Tjaden & Thoennes, 2000). Therefore, there is a great need 
to work with men and boys as community leaders and change agents to 
prevent sexual violence/intimate partner violence (SV/IPV). As 
previously indicated, research suggests that racial/ethnic minorities 
bear a greater potential risk of victimization.
    Purpose: The purpose of this program announcement is to integrate 
prevention principles, concepts and practices into racial/ethnic 
minority community efforts to address sexual and intimate partner 
violence. This program is intended to assist racial/ethnic minority 
communities to assess and prevent sexual and intimate partner violence. 
An emphasis will be placed on building capacity to work with men and 
boys in a culturally appropriate manner to prevent these forms of 
violence before they occur. The outcomes of interest will be achieved 
through four key processes: collaboration, planning, implementation, 
and evaluation. This program addresses the ``Healthy People 2010'' 
focus area(s) of Injury and Violence Prevention.
    For the purposes of this program announcement the following 
definitions apply:
    Sexual Violence (SV) includes a wide range of acts that occur in a 
variety of settings. There are four types of sexual violence (Basile & 
Saltzman, 2002): (1) A completed sex act without the victim's consent, 
or involving a victim who is unable to provide consent or refuse. A sex 
act is defined as contact between the penis and the vulva or the penis 
and the anus involving penetration, however slight; contact between the 
mouth and penis, vulva, or anus; or penetration of the anal or genital 
opening of another person by a hand, finger, or other object. (2) An 
attempted (but not completed) sex act without the victim's consent, or 
involving a victim who is unable to provide consent or refuse. (3) 
Abusive sexual contact including intentional touching, either directly 
or through the clothing, of the genitalia, anus, groin, breast, inner 
thigh, or buttocks of any person without his or her consent, or of a 
person who is unable to consent or refuse. (4) Non-contact sexual abuse 
including voyeurism; intentional exposure of an individual to 
exhibitionism; pornography; verbal or behavioral sexual harassment; 
threats of sexual violence to accomplish some other end; or taking nude 
photographs of a sexual nature of another person without his or her 
consent or knowledge, or of a person who is unable to consent or 
refuse.
    Intimate Partner Violence (IPV) is actual or threatened physical or 
sexual violence or psychological and emotional abuse directed toward a 
spouse, ex-spouse, current or former boyfriend or girlfriend, or 
current or former dating partner. Intimate partners represent various 
types of relationships and may be heterosexual or of the same sex. Some 
of the common terms used to describe intimate partner violence are 
domestic abuse, spouse abuse, domestic violence, courtship violence, 
battering, marital rape, and date rape (Saltzman, et al. 1999).
    Primary Prevention--Individual, relationship or family, and/or 
community level strategies, policies and actions that prevent violence 
from initially occurring, including risk reduction. Primary prevention 
efforts work to modify and/or entirely eliminate the event, conditions, 
situations, or exposure to influences (risk factors) that result in the 
initiation of violence and associated injuries, disabilities, and 
deaths. Additionally, prevention efforts seek to identify and enhance 
protective factors that may prevent violence not only in at-risk 
populations but also in the community at large.
    Racial/Ethnic Minority Communities--For the purpose of this program 
announcement, racial minorities are African American, American Indian 
or Alaska Native, Asian, Native Hawaiian or Other Pacific Islander. 
Ethnicity refers to Hispanic populations. Racial/ethnic minority 
communities are identified as experiencing a higher incidence and 
prevalence of SV/IPV as compared to the national average.
    Measurable outcomes of the program will be in alignment with the 
following performance goal for the National Center for Injury 
Prevention and Control (NCIPC): Goal 1--Increase the capacity of injury 
prevention and control programs to address prevention of injuries and 
violence. This announcement is only for non-research activities 
supported by the Centers for Disease Control and Prevention. If 
research is proposed, the application will not be reviewed. For the 
definition of research, please see the CDC Web site at the following 
Internet address: https://www.cdc.gov/od/ads/opspoll1.htm.

Activities

    Awardee activities for this program are as follows:
    1. Conduct:
     An assessment of existing data that describes the known 
risk and protective factors related to the perpetration of SV/IPV 
within racial/ethnic minority populations.
     An analysis of existing program inventories directed at 
identifying program models and efforts to involve men and boys in 
ending SV/IPV and to determine the extent to which such efforts are 
reaching and/or applicable to working within racial/ethnic minority 
communities.
     An assessment of Baseline Knowledge, Attitudes, Beliefs 
and Behaviors (KABB) related to the prevention of SV/IPV. Examples can 
include men and boys knowledge, attitudes, beliefs or behavior around 
bystander action in relation to individual behavior and personal 
responsibility; assets or barriers at the community level; 
characteristics of community norms related to SV/IPV.
    2. Create a leadership consortium. The leadership consortium must 
include participation from the recipient agency, and a minimum of four 
other agencies/organizations. The five organizations/agencies must 
represent and bring together a focus and understanding within the 
following areas of expertise:
     Sexual violence and intimate partner violence, including 
risk reduction and other public health approaches to preventing SV/IPV.
     Community leaders.
     Effective strategies to engage men and boys in preventing 
SV/IPV.
     Public health.
     Program evaluation.
    3. Create an advisory committee that includes public and private 
partners that can facilitate reaching men and boys and other partners. 
The applicant should distinguish the function of the

[[Page 17088]]

advisory committee from those of the leadership consortium.
    4. Participate in a cross-site evaluation.
    5. Develop or adapt a culturally relevant program model that 
engages men and boys in the prevention of SV/IPV. The awardee should 
take into consideration relevance and community salience and existing 
program models identified through the analysis of existing program 
inventories.
    6. Deliver, test and evaluate this program model in at least one 
and no more than three communities. This program model should include 
efforts addressing multiple system levels of prevention (at least 2, 
individual, relationship, and/or, community). Note: Five to ten percent 
of the Awardee's budget should be allocated to support the evaluation 
component of this project (e.g. staff time, travel, subject matter 
expert speaker, data collection).
    7. Develop and implement a comprehensive evaluation plan that 
supports:
     Baseline and follow-up assessments and the formative work 
necessary to develop and test the program model
     A logic model to support building capacity to work with 
men and boys in a culturally appropriate manner to prevent SV/IPV 
before they occur.
     Data collection required to assess the capacity building 
measures and impact of this program model
    Activities to build capacity within Awardee's Organization:
     Participate in training and technical assistance 
activities and opportunities directly related to this program 
announcement provided by CDC and training and technical assistance 
activities and opportunities indirectly related to this program 
announcement (i.e. UNC PREVENT) where appropriate and feasible.
     Institutionalize prevention principles, concepts and 
practices within the recipient organization beyond the knowledge and 
skills of the funded program staff.
     Establish a two-way process for systems to monitor and 
provide feedback to and from racial/ethnic minority communities.
     Compile and disseminate program results, including but not 
limited to dissemination to other organizations that serve racial/
ethnic minority communities and relevant CDC programs (Rape Prevention 
and Education RPE), Domestic Violence Prevention Enhancements Through 
Leadership and Alliances (DELTA), Enhancing State Capacity to Address 
Child and Adolescent Health Through Violence Prevention (ESCAPe).
    Awardee activities to build capacity in racial/ethnic minority 
communities (in at least one and not more than three):
     Provide primary prevention-focused training (including 
risk reduction), technical assistance and funding. The awardee should 
establish and describe relevant selection criteria for the 
determination of these communities. Primary prevention-focused training 
and technical assistance for programs on working with men and boys to 
prevent SV/IPV should meet the definition of prevention principles, 
concepts and practices.
     Provide training and technical assistance to communities 
for programs on working with men and boys on the concepts of SV/IPV 
prevention including risk reduction, individual behavior change, 
community organizing, strategic planning, program development 
implementation and evaluation.
     Support and provide assistance to communities on the 
selected program model. Monitor the activities of the community to 
ensure that the model program is implemented in a comprehensive manner 
and with fidelity to the tested model.
     Assist communities in the development of an evaluation 
plan and monitor the extent to which this plan is implemented.
    In a cooperative agreement, CDC staff is substantially involved in 
the program activities, above and beyond routine grant monitoring.
    CDC Activities for this program are as follows:
    1. Participate in the translation of prevention principles, 
concepts and practices into prevention-focused activities, strategies, 
and policies that can be integrated into the program model.
    2. Provide guidance on how to identify an evaluation contractor and 
approving the hire of applicant's evaluation contractor.
    3. Approve the staff and contractors funded through the program.
    4. Provide support and assistance in the evaluation of the program 
model to be implemented within 1-3 communities (see Awardee Activity 
5).
    5. Facilitate and provide technical assistance for the cross-site 
evaluation.
    6. Coordinate capacity-building prevention-focused training and 
technical assistance for the grantee.
    7. Provide assistance in the management and technical performance 
of the implementation of prevention principles, concepts, practices, 
leadership, activities, and strategies.
    8. Arrange for information sharing with other CDC grantees 
including but not limited to DELTA, RPE, and ESCAPe.
    9. Share new evaluation/research information.

II. Award Information

    Type of Award: Cooperative Agreement. CDC involvement in this 
program is listed in the Activities Section above.
    Fiscal Year Funds: 2005.
    Approximate Total Funding: $300,000.
    Approximate Number of Awards: Two.
    Approximate Average Award: $150,000. (This amount is for the first 
12-month budget period, and includes both direct and indirect costs.)
    Floor of Award Range: $150,000 (CDC will not make an award smaller 
than the floor amount).
    Ceiling of Award Range: $150,000. (This ceiling is for the first 
12-month budget period. CDC will not make an award for larger than the 
ceiling amount.)
    Anticipated Award Date: September 29, 2005.
    Budget Period Length: 12 months.
    Project Period Length: Three years with a possibility for five 
years total. (An initial three-year project period is specified with 
the anticipation of an additional two years with year four and five 
contingent on the accomplishment of very specific outcomes in years one 
through three.)
    Milestones and success necessary to continue into Years four and 
five.
    The awardee has developed and implemented an inventory and series 
of KABB assessments that address the following:
     The presence or absence of efforts that are directed at 
engaging men and boys in ending SV/IPV.
     The individual, organizational and community level 
indicators that represent assets or barriers to implementing prevention 
strategies.
     The awardee has developed a leadership consortium 
comprised of adequate representation as outlined in the program 
announcement and has implemented a feedback mechanism that assesses the 
contribution and role of member organizations.
     The awardee has developed or modified an advisory 
committee comprised of adequate representation as outlined in the 
program announcement and has implemented a feedback mechanism that 
assesses the contribution and role of each member organization.
     The awardee has developed and tested (formative) a 
culturally relevant program model for working with men and boys in the 
prevention of SV/IPV.

[[Page 17089]]

     The awardee has developed a program logic model that 
specifies short term or intermediate markers (KABB, community capacity 
measures, etc.).
     The awardee has developed selection criteria to be used to 
objectively assess the sites being considered for the implementation of 
the program model.
     Implementation of the program model has been initiated in 
no more than three program sites.
     An evaluation plan has been developed, measures identified 
or developed and the baseline data collected.

Throughout the project period, CDC's commitment to continuation of 
awards will be conditioned on the availability of funds, evidence of 
satisfactory progress by the applicant (as documented in required 
reports), and the determination that continued funding is in the best 
interest of the Federal Government.

III. Eligibility Information

III.1. Eligible Applicants

    This program is directed to:
     Public and private nonprofit organizations with at least 
three years experience in addressing violence against women or women's 
health issues at a regional or national level. They must also 
demonstrate that 85 percent of the population served within the last 
three years represent one racial/ethnic minority population.

--Or--
     Regional or national organizations representing consortia 
or coalitions of American Indian communities or Alaska Native villages. 
Examples of such organizations would include area or regional health 
boards, inter-tribal councils, tribal chairmen's health boards.

III.2. Cost Sharing or Matching

    Matching funds are not required for this program.

III.3. Other

    If you request a funding amount greater than the ceiling of the 
award range, your application will be considered non-responsive, and 
will not be entered into the review process. You will be notified that 
your application did not meet the submission requirements.
Special Requirements
    If your application is incomplete or non-responsive to the special 
requirements listed in this section, it will not be entered into the 
review process. You will be notified that your application did not meet 
submission requirements.
     Late applications will be considered non-responsive. See 
section ``IV.3. Submission Dates and Times'' for more information on 
deadlines.
     The application is required to clearly specify the one 
racial/ethnic community to be served.
     Non-profit 501(c)(3) status--provide copy of IRS 
determination letter with LOI and application.
     Note: Title 2 of the United States Code section 1611 
states that an organization described in section 501(c)(4) of the 
Internal Revenue Code that engages in lobbying activities is not 
eligible to receive Federal funds constituting an award, grant, or 
loan.

IV. Application and Submission Information

IV.1. Address To Request Application Package

    To apply for this funding opportunity use application form PHS 
5161-1.
Electronic Submission
    CDC strongly encourages you to submit your application 
electronically by utilizing the forms and instructions posted for this 
announcement on https://www.Grants.gov, the official Federal agency wide 
E-grant Web site. Only applicants who apply online are permitted to 
forego paper copy submission of all application forms.
Paper Submission
    Application forms and instructions are available on the CDC Web 
site, at the following Internet address: https://www.cdc.gov/od/pgo/
forminfo.htm.
Pre-Application Conference Call
    For interested applicants, one pre-application technical assistance 
call will be conducted. The call will be held for one hour on April 19, 
2005, from 2-3 p.m. e.s.t. Please e-mail Rebeca Lee-Pethel at rlee-
pethel@cdc.gov by April 11, 2005, to request the conference call number 
and code. The conference call number and code will be provided via e-
mail. The conference call name is Preventing Sexual and Intimate 
Partner Violence within Racial/Ethnic Minority Communities.

IV.2. Content and Form of Submission

    Letter of Intent (LOI): Your LOI must be written in the following 
format:
     Maximum number of pages: Two.
     Font size: 12-point unreduced.
     Double spaced.
     Paper size: 8.5 by 11 inches.
     Page margin size: One inch.
     Printed only on one side of page.
     Written in plain language, avoid jargon.

Your LOI must contain the following information:

     Name of organization.
     Stated intent to submit an application for the Preventing 
Sexual and Intimate Partner Violence within Racial/Ethnic Minority 
Communities and clearly specifying the one racial/ethnic community to 
be served.
     Signature of Program Official and Financial Officer.
     IRS 501(c)(3) determination letter as page 2.
Application
    Electronic Submission: You may submit your application 
electronically at: https://www.grants.gov. Applications completed online 
through Grants.gov are considered formally submitted when the applicant 
organization's Authorizing Official electronically submits the 
application to https://www.grants.gov. Electronic applications will be 
considered as having met the deadline if the application has been 
submitted electronically by the applicant organization's Authorizing 
Official to Grants.gov on or before the deadline date and time.
    It is strongly recommended that you submit your grant application 
using Microsoft Office products (e.g., Microsoft Word, Microsoft Excel, 
etc.). If you do not have access to Microsoft Office products, you may 
submit a PDF file. Directions for creating PDF files can be found on 
the Grants.gov Web site. Use of file formats other than Microsoft 
Office or PDF may result in your file being unreadable by our staff.
    CDC recommends that you submit your application to Grants.gov early 
enough to resolve any unanticipated difficulties prior to the deadline. 
You may also submit a back-up paper submission of your application. Any 
such paper submission must be received in accordance with the 
requirements for timely submission detailed in Section IV.3. of the 
grant announcement. The paper submission must be clearly marked: 
``BACK-UP FOR ELECTRONIC SUBMISSION.'' The paper submission must 
conform with all requirements for non-electronic submissions. If both 
electronic and back-up paper submissions are received by the deadline, 
the electronic version will be considered the official submission.
    Paper Submission: If you plan to submit your application by hard 
copy, submit the original and two hard copies of your application by 
mail or express delivery service. Refer to section IV.6. Other 
Submission Requirements for submission address.
    You must submit a project narrative with your application forms. 
The

[[Page 17090]]

narrative must be submitted in the following format:
     Maximum number of pages: 25--If your narrative exceeds the 
page limit, only the first 25 pages will be reviewed.
     Font size: 12 point unreduced.
     Double spaced.
     Paper size: 8.5 by 11 inches.
     Page margin size: One inch.
     Printed only on one side of page.
     Held together only by rubber bands or metal clips; not 
bound in any other way.
    Your narrative should address activities to be conducted over the 
entire 3 year project period, and must include the following items in 
the order listed:
    1. Applicant Organization History, Description and Capacity.
    2. Applicant's Plan for Implementing This Cooperative Agreement.
    3. Collaboration.
    4. Evaluation.
    5. Applicant's Management and Staffing.
    6. Measures of Effectiveness.
    7. Budget Justification (does not count towards 25 page limit).
    Additional information may be included in the application 
appendices. The appendices will not be counted toward the narrative 
page limit (do not use staples). This additional information includes:
    1. Curriculum Vitae.
    2. Job Descriptions.
    3. Resumes.
    4. Organizational Charts.
    5. Letters of Support, etc.
    6. Logic Model.
    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. The DUNS number is a nine-digit 
identification number, which uniquely identifies business entities. 
Obtaining a DUNS number is easy and there is no charge. To obtain a 
DUNS number, access www.dunandbradstreet.com or call 1-866-705-5711.
    For more information, see the CDC Web site at: https://www.cdc.gov/
od/pgo/funding/pubcommt.htm. If your application form does not have a 
DUNS number field, please write your DUNS number at the top of the 
first page of your application, and/or include your DUNS number in your 
application cover letter.
    Additional requirements that may require you to submit additional 
documentation with your application are listed in section ``VI.2. 
Administrative and National Policy Requirements.''

IV.3. Submission Dates and Times

    LOI Deadline Date: May 4, 2005. CDC requests that you submit a LOI 
if you intend to apply for this program. Although the LOI is not 
required, not binding, and does not enter into review of your 
subsequent application, the LOI will be used to gauged the level of 
interest in this program, and to allow CDC to plan the application 
review.
    Application Deadline Date: May 19, 2005.
    Explanation of Deadlines: LOIs and Applications must be received in 
the CDC Procurement and Grants Office by 4 p.m. Eastern Time on the 
deadline date. If you submit your LOI or application by the United 
States Postal Service or commercial delivery service, you must ensure 
that the carrier will be able to guarantee delivery by the closing date 
and time. If CDC receives your submission after closing due to: (1) 
Carrier error, when the carrier accepted the package with a guarantee 
for delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, you will be given the opportunity to 
submit documentation of the carriers guarantee. If the documentation 
verifies a carrier problem, CDC will consider the submission as having 
been received by the deadline.
    This announcement is the definitive guide on LOI and application 
content, submission address, and deadline. It supersedes information 
provided in the application instructions. If your submission does not 
meet the deadline above, it will not be eligible for review, and will 
be discarded. You will be notified that you did not meet the submission 
requirements.
    Electronic Submission: If you submit your application 
electronically with Grants.gov, your application will be electronically 
time/date stamped which will serve as receipt of submission. In turn, 
you will receive an e-mail notice of receipt when CDC receives the 
application. All electronic applications must be submitted by 4 p.m. 
Eastern Time on the application due date.
    Paper Submission: CDC will not notify you upon receipt of your 
paper submission. If you have a question about the receipt of your LOI 
or application, first contact your courier. If you still have a 
question, contact the PGO-TIM staff at: 770-488-2700. Before calling, 
please wait two to three days after the submission deadline. This will 
allow time for submissions to be processed and logged.

IV.4. Intergovernmental Review of Applications

    Executive Order 12372 does not apply to this program.

IV.5. Funding restrictions

    Restrictions, which must be taken into account while writing your 
budget, are as follows:
     Funds may not be used for research.
     Reimbursement of pre-award costs is not allowed.
     Budgets for each program year should include travel costs 
for a representative from each of the organizations on the leadership 
consortium and the applicant's evaluation contractor to attend a 3-day 
planning and training meeting in Atlanta, Georgia with CDC staff.
     Applicants are required, at a minimum, to have the 
equivalent of one full time employee assigned to the programmatic 
activities.
     Funding may not be used for construction.
     Funding may be used to purchase computer equipment and 
software and internet connection equipment and software.
     Funding may not be used to provide direct services to 
victims or perpetrators of SV/IPV.
     Funding will not be given to two applicants representing 
the same racial/ethnic minority population. It is necessary for the 
project to ensure that funding will go towards more than one particular 
racial or ethnic minority.
    If you are requesting indirect costs in your budget, you must 
include a copy of your indirect cost rate agreement. If your indirect 
cost rate is a provisional rate, the agreement should be less than 12 
months of age. Guidance for completing your budget can be found on the 
CDC Web site, at the following Internet address: https://www.cdc.gov/od/
pgo/funding/budgetguide.htm.

IV.6. Other Submission Requirements

    LOI Submission Address: Submit your LOI by express mail, or 
delivery service to: Rebeca Lee-Pethel, Project Officer, National 
Center for Injury Prevention and Control, Koger/Vanderbilt Building, 
2939 Flowers Road, Atlanta, GA 30341, Telephone: 770-488-1224, Fax: 
770-488-1360, E-mail: rlee-pethel@cdc.gov.
Application Submission Address
    Electronic Submission: CDC strongly encourages applicants to submit 
electronically at: https://www.grants.gov. You will be able to download 
a copy of the application package from https://www.grants.gov, complete 
it offline, and then upload and submit the application via the 
Grants.gov site. E-mail

[[Page 17091]]

submissions will not be accepted. If you are having technical 
difficulties in Grants.gov they can be reached by e-mail at 
support@grants.gov or by phone at 1-800-518-4726 (1-800-518-GRANTS). 
The Customer Support Center is open from 7 a.m. to 9 p.m. eastern time, 
Monday through Friday.
    Paper Submission: If you chose to submit a paper application, 
submit the original and two hard copies of your application by mail or 
express delivery service to: Technical Information Management--RFA 
05043, CDC Procurement and Grants Office, 2920 Brandywine Road, 
Atlanta, GA 30341.

V. Application Review Information

V.1. Criteria

    Applicants are required to provide measures of effectiveness that 
will demonstrate the accomplishment of the various identified 
objectives within the Purpose and Awardee Activities sections of the 
cooperative agreement. Measures effectiveness must relate to the 
performance goals stated in the ``Purpose'' section of this 
announcement: Increase the capacity of injury prevention and control 
programs to address the prevention of injuries and violence. Measures 
must be objective and quantitative, and must measure the intended 
outcome. Applicants are expected to develop four measures of 
effectiveness, one for each level of capacity-building: collaboration, 
planning, implementation and evaluation. Measures of effectiveness will 
be an element of evaluation.
    Your application will be evaluated against the following criteria:
1. Plans for Development and Implementation (30 Points)
    a. Does the applicant adequately describe the problem of SV/IPV 
within the population they serve? Is this supported by government 
reports and credible research sources?
    b. Does the applicant describe plans for conducting an assessment 
of existing data that describes known risk and protective factors for 
SV/IPV within one specific racial/ethnic community?
    c. Does the applicant describe plans for conducting an analysis of 
existing prevention program inventories?
    d. Does the applicant describe plans for conducting a baseline 
assessment of Knowledge, Attitudes, Beliefs and Behaviors (KABB) and 
community assets and barriers related to the prevention of SV/IPV?
    e. Does the applicant describe plans for selecting the one to three 
racial/ethnic communities for technical assistance and funding?
    f. Does the applicant describe plans for developing the leadership 
consortium?
    g. Does the applicant describe plans for developing an advisory 
committee?
    h. Does the applicant include plans for working with CDC, the 
advisory committee and leadership consortium to reach consensus and 
uniformity in selecting core measures, tools and processes for capacity 
building measures and the program model development and implementation?
    i. Does the applicant demonstrate a clear plan for effectively 
involving various stakeholders (state, local, regional, and/or racial/
ethnic minority communities) in the assessment and planning processes?
    j. Is the plan adequate to carry out the proposed objectives? Are 
the proposed methods feasible and to what extent will they accomplish 
the program goals? Are the goals and objectives specific, measurable, 
achievable, realistic and time-specific? Are roles and responsibilities 
clearly identified?
    k. Does the applicant describe a plan to identify model programs or 
resources that are directed to work with men and boys and a plan for 
testing these messages, strategies and approaches with approaches 
within one racial/ethnic minority community?
2. Applicant Organization History, Description and Capacity (25 Points)
    a. Does the applicant demonstrate its history and capacity in 
providing leadership and guidance to racial/ethnic minority community 
efforts, including a clear description of its linkages with and role in 
support for the racial/ethnic minority community addressed in this 
proposal? Does the applicant demonstrate 85 percent of the population 
they serve are of the racial/ethnic minority group proposed in this 
application? Does the applicant demonstrate experience addressing 
violence against women or women's health issues (minimum of three 
years)?
    b. Does the applicant demonstrate its experience as well as its 
current ability to provide leadership at a regional or national 
organizational level?
    c. Does the applicant demonstrate its experience and a description 
of its current capacity to provide leadership in involving other 
agencies?
    d. Does the applicant demonstrate its organizational experience and 
current capacity to provide training and technical assistance?
    e. Does the applicant demonstrate experience in developing and 
implementing an evaluation plan? Does the applicant have experience 
using data to determine organizational priorities?
3. Collaboration (20 Points)
    a. Does the applicant describe the composition, role and 
involvement of the leadership consortium, and identify or propose 
participants representing a broad range of disciplines that include 
expertise in SV/IPV, Tribal or community leaders and/or elders, 
prevention and public health approaches to preventing SV/IPV, and 
evaluation?
    b. Does the applicant include resource agreements between 
leadership consortium agencies (this can be included as direct 
contracts or in-kind reflected within the proposed budget)? Does the 
applicant include memorandum of agreement or contractual agreements 
with the leadership consortium organizations? Does the applicant 
describe how the partner organizations will be involved in the data 
identification, collection, etc?
    c. Does the applicant describe the composition, role and 
involvement of the advisory committee, and identify or propose 
participants representing public and private partners that can 
facilitate reaching men and boys and other partners?
    d. Does the applicant describe the roles and responsibilities for 
both the advisory committee and leadership consortium? Does the 
applicant describe how these two groups will work together?
    e. Does the applicant demonstrate a willingness to collaborate with 
CDC on all aspects of this project? Does the applicant demonstrate a 
willingness to collaborate with relevant CDC awardees and partners?
    f. Does the applicant demonstrate experience and leadership in 
working with racial/ethnic minority communities by also including 
letters of support and/or memoranda of agreement from organizations, 
research and/or academic experts/institutions, and other agencies and 
organizations, including public health agencies and organizations that 
work with racial/ethnic minority communities and agencies working with 
men and boys?
4. Evaluation (15 Points)
    a. Does the applicant provide a draft logic model that supports 
building capacity to work with men and boys in a culturally appropriate 
manner to prevent SV/IPV before they occur and represents the program 
model being delivered? Does this draft logic model identify outcome 
measures at a minimum of 2 levels and include

[[Page 17092]]

individual behavior and personal responsibility? For assistance on how 
to design a logic model, access CDC's Web site: https://www.cdc.gov/
nccdphp/dnpa/physical/handbook/step2.htm.
    b. Does the applicant demonstrate a willingness to collaborate with 
CDC evaluation experts?
    c. Does the applicant allocate 5-10 percent of the budget to 
support the evaluation component of this project?
5. Staffing (10 Points)
    a. Does the applicant describe the responsibilities of individual 
staff members, including their level of effort and allocation of time? 
Does the applicant identify at least one full time employee to manage 
this project?
    b. Does the applicant describe project staff and their relevant 
skills and expertise working with racial/ethnic minority communities 
and for their assigned tasks relative to this announcement? Are 
Curriculum Vitas and job descriptions provided?
    c. Does the applicant include an organizational chart?
6. Measures of Effectiveness (Not Scored)
7. Proposed Budget and Justification (Not Scored)

V.2. Review and Selection Process

    Applications will be reviewed for completeness by the Procurement 
and Grants Office (PGO) staff, and for responsiveness by the National 
Center for Injury Prevention and Control (NCIPC). Incomplete 
applications and applications that are non-responsive to the 
eligibility criteria will not advance through the review process. 
Applicants will be notified that their application did not meet 
submission requirements.
    An objective review panel comprised of CDC employees will evaluate 
complete and responsive applications according to the criteria listed 
in the ``V.1. Criteria'' section above. In addition, the following 
factors may affect the funding decision:
     Maintaining geographic diversity.
     Ensuring that racial/ethnic minority communities are 
represented by funding two applicants which reflect racial/ethnic 
minority communities who experience a higher incidence and prevalence 
of SV/IPV as compared to the national average through adequate service 
experience and organizational representation.
     Ensuring that the two awardees are not representing the 
same racial/ethnic minority population.
    CDC will provide justification for any decision to fund out of rank 
order.

V.3. Anticipated Announcement and Award Dates

    Anticipated Announcement Date: September 1, 2005.
    Anticipated Award Date: September 1, 2005.

VI. Award Administration Information

VI.1. Award Notices

    Successful applicants will receive a Notice of Award (NOA) from the 
CDC Procurement and Grants Office. The NOA shall be the only binding, 
authorizing document between the applicant and CDC. The NOA will be 
signed by an authorized Grants Management Officer, and mailed to the 
applicant fiscal officer identified in the application. Unsuccessful 
applicants will receive notification of the results of the application 
review by mail.

VI.2. Administrative and National Policy Requirements

45 CFR Part 74 and Part 92
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: https://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
    An additional Certifications form from the PHS5161-1 application 
needs to be included in your Grants.gov electronic submission only. 
Refer to https://www.cdc.gov/od/pgo/funding/PHS5161-1-Certificates.pdf. 
Once the form is filled out attach it to your Grants.gov submission as 
Other Attachments Form.
    The following additional requirements apply to this project:
     AR-9 Paperwork Reduction Act Requirements.
     AR-10 Smoke-Free Workplace Requirements.
     AR-11 Healthy People 2010.
     AR-12 Lobbying Restrictions.
     AR-13 Prohibition on Use of CDC Funds for Certain Gun 
Control Activities.
     AR-14 Accounting System Requirements.
     AR-15 Proof of Non-Profit Status.
     AR-16 Security Clearance Requirement.
     AR-25 Release and Sharing of Data.

Additional information on these requirements can be found on the CDC 
Web site at the following Internet address: https://www.cdc.gov/od/pgo/
funding/ARs.htm.

VI.3. Reporting Requirements

    You must provide CDC with an original, plus two hard copies of the 
following reports:
    1. Interim progress report, due no less than 90 days before the end 
of the budget period. The progress report will serve as your non-
competing continuation application, and must contain the following 
elements:
    a. Current Budget Period Activities Objectives (for first six 
months of budget period).
    b. Current Budget Period Financial Progress.
    c. New Budget Period Program Proposed Activity Objectives (provides 
updated logic models and narratives).
    d. Budget.
    e. Measures of Effectiveness.
    f. Additional Requested Information.
    2. Annual progress report, due 90 days after the end of the budget 
period.
    a. Current Budget Period Activities Objectives (for second six 
months of budget period).
    b. New Budget Period Program Proposed Activity Objectives (provides 
updated logic models and narratives).
    c. Measures of Effectiveness.
    d. Additional Requested Information.
    3. Financial status report, due no more than 90 days after the end 
of the budget period.
    4. Final financial and performance reports, no more than 90 days 
after the end of the project period.
    These reports must be mailed to the Grants Management or Contract 
Specialist listed in the ``Agency Contacts'' section of this 
announcement.

VII. Agency Contacts

    We encourage inquiries concerning this announcement. For general 
questions, contact: Technical Information Management Section, CDC 
Procurement and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341, 
Telephone: 770-488-2700.
    For program technical assistance, contact: Rebeca Lee-Pethel, 
Project Officer, National Center for Injury Prevention and Control, 
4770 Buford Highway, NE Mailstop K60, Atlanta, GA 30341, Telephone: 
770-488-1224, Fax: 770-488-1360, E-mail: rlee-pethel@cdc.gov.
    For financial, grants management, or budget assistance, contact: 
Brenda Hayes, Grants Management Specialist, CDC Procurement and Grants 
Office, 2920 Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-
2741, Fax: 770/488-2670, E-mail: BKH4@cdc.gov.

VIII. Other Information

    This and other CDC funding opportunity announcements can be found 
on the CDC Web site, Internet address: https://www.cdc.gov. Click on 
``Funding'' then ``Grants and Cooperative Agreements.''


[[Page 17093]]


    Dated: March 28, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 05-6580 Filed 4-1-05; 8:45 am]
BILLING CODE 4163-18-P